Skye Bioscience, Inc. (SKYE)
USD 3.01
(-7.38%)
USD 3.01
(-7.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -13.95 Million | -12.74 Million | -6.47 Million | -6.05 Million | -6.02 Million | -3.94 Million |
| Net Income | -37.64 Million | -19.48 Million | -8.52 Million | -6.56 Million | 1.05 Million | -19.19 Million |
| Depreciation & Amortization | 124.25 Thousand | 114.99 Thousand | 34.13 Thousand | 1872.00 | 1462.00 | 1544.00 |
| Deferred income taxes | - | - | -96.78 Thousand | -436.27 Thousand | -8.68 Million | 14.26 Million |
| Stock-based compensation | 987.51 Thousand | 629.03 Thousand | 869.2 Thousand | 302.74 Thousand | 680.45 Thousand | 674.96 Thousand |
| Change in working capital | -469.3 Thousand | -761.9 Thousand | 646.94 Thousand | 94.19 Thousand | 295.71 Thousand | 100.19 Thousand |
| Other non-cash items | 24.98 Million | 6.75 Million | 593.8 Thousand | 544.03 Thousand | 629.29 Thousand | 205.52 Thousand |
| Investing Cash Flow | 6.59 Million | 5.21 Million | -90.86 Thousand | -7230.00 | - | -4385.00 |
| Investments in PPE | -12.55 Thousand | -28.06 Thousand | -90.86 Thousand | -7230.00 | - | -4385.00 |
| Acquisitions | 1.07 Million | 5.3 Million | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 5.53 Million | - | - | - | - | - |
| Other Investing Activities | 1.07 Million | -66.45 Thousand | - | - | - | - |
| Financing Cash Flow | 16.44 Million | -208.79 Thousand | 13.07 Million | 6.7 Million | 6 Million | 5.54 Million |
| Debt repayment | -4.71 Million | -891.66 Thousand | - | -566.7 Thousand | -3.98 Million | -2.34 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 11.73 Million | 1967.00 | 6.06 Million | 6.08 Million | 1.91 Million | 9794.00 |
| Other Financing Activities | 16.7 Million | 680.9 Thousand | 7.01 Million | 1.18 Million | 8.07 Million | 5.53 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -701.28 Thousand | 799.74 Thousand | 518.63 Thousand | 241.56 Thousand | 134.21 Thousand | -85.32 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 231.97 Thousand | -1.56 Million | 128.3 Thousand | -147.37 Thousand | 161.5 Thousand | 185.51 Thousand |
| Cash at beginning of period | 1.24 Million | 8.98 Million | 2.47 Million | 1.83 Million | 1.85 Million | 264.38 Thousand |
| Cash at end of period | 10.33 Million | 1.24 Million | 8.98 Million | 2.47 Million | 1.83 Million | 1.85 Million |
| Capital Expenditure | -12.55 Thousand | -28.06 Thousand | -90.86 Thousand | -7230.00 | - | -4385.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 9.08 Million | -7.73 Million | 6.51 Million | 639.46 Thousand | -23.37 Thousand | 1.59 Million |
| Free Cash Flow | -13.96 Million | -12.77 Million | -6.56 Million | -6.06 Million | -6.02 Million | -3.94 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.9 Million | -5.01 Million | -37.64 Million | -4.41 Million | -24.94 Million | -3.11 Million |
| Depreciation & Amortization | 29.79 Thousand | 27.56 Thousand | 124.25 Thousand | 28.37 Thousand | 28.78 Thousand | 33.91 Thousand |
| Deferred income taxes | - | - | - | -21.21 Million | 21.21 Million | 1.00 |
| Stock-based compensation | 1.82 Million | 2.47 Million | 987.51 Thousand | 592.85 Thousand | 160.2 Thousand | 102.87 Thousand |
| Change in working capital | -1.55 Million | -1.28 Million | -469.3 Thousand | -110.57 Thousand | -592.15 Thousand | 952.54 Thousand |
| Other non-cash items | 250.32 Thousand | 237.2 Thousand | 24.98 Million | 1.18 Million | 79.08 Thousand | 30.32 Thousand |
| Investing Cash Flow | -32.46 Thousand | 1.14 Million | 6.59 Million | -7017.00 | 1.07 Million | - |
| Investments in PPE | -32.46 Thousand | -3181.00 | -12.55 Thousand | -7017.00 | -3673.00 | - |
| Acquisitions | - | - | 1.07 Million | - | 1.07 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 5.53 Million | -5.53 Million | - | - |
| Other Investing Activities | - | 1.14 Million | 1.07 Million | 5.53 Million | - | - |
| Financing Cash Flow | -2.09 Million | 85.65 Million | 16.44 Million | -22.65 Thousand | 16.63 Million | -123.41 Thousand |
| Debt repayment | - | - | -4.71 Million | -22.65 Thousand | -73.98 Thousand | -123.41 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -2.09 Million | 85.65 Million | 11.73 Million | -11.73 Million | 11.73 Million | - |
| Other Financing Activities | - | - | 16.7 Million | 11.72 Million | 4.97 Million | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -15.64 Thousand | -60.65 Thousand | -701.28 Thousand | -475.66 Thousand | -90.53 Thousand | 331.14 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.54 Million | - | 231.97 Thousand | 365.09 Thousand | -501.62 Thousand | 621.39 Thousand |
| Cash at beginning of period | 92.42 Million | 10.33 Million | 1.24 Million | 14.21 Million | 558.03 Thousand | 2.67 Million |
| Cash at end of period | 83.2 Million | 92.42 Million | 10.33 Million | 10.33 Million | 14.21 Million | 558.03 Thousand |
| Capital Expenditure | -32.46 Thousand | -3181.00 | -12.55 Thousand | -7017.00 | -3673.00 | - |
| Effect of forex changes on cash | - | - | - | 13.55 Million | -13.55 Million | - |
| Net cash flow / Change in cash | -9.22 Million | 82.08 Million | 9.08 Million | -3.87 Million | 13.65 Million | -2.11 Million |
| Free Cash Flow | -7.12 Million | -4.71 Million | -13.96 Million | -3.85 Million | -4.05 Million | -1.99 Million |
MCOA
SLHGF
CHHHF
034310
MPHYF
CLWT